Eye on Advocacy

Shop

Advocacy /

Eye on Advocacy

View Topics

News by Topic

All Topics

Advocacy Works

Affordable Care Act

ASC Payment

ASC Quality Reporting

Audits

Community Health Centers

Compounding

Congressional Advocacy

Contact Lens Safety

Coronavirus

Drug Pricing

Drug Shortages

Drug Waste

E/M Codes

Electronic Health Records

Eyedrop Refills

Eyeglass Rule

FDA/Tech Innovation

Federal Supremacy Project

Global Surgery Payments

Health IT

ICD-10

Low-Vision Device Coverage

MACRA

Meaningful Use

Medicare Advantage

Medicare Fee Schedule

Medicare Payment Reform

Merit-Based Incentive Payment System

Network Adequacy/Access to Care

Open Payments/Financial Disclosures

Patient Safety

Performance Data Releases

PQRS

Prior Authorization

Public Health

Research Funding

Rubber Bullets

RUC Updates

Scleral Tattoo

Scope of Practice

Sequestration

SGR

Step Therapy

Surprise Medical Billing

Telemedicine

Stimulus

Third-party Payers

Truth in Advertising

Value-Based Modifier

Veterans Eye Care

Vision Screenings

Visionary Awards

Workforce Shortages
View Issue List

Issue Summaries

ASC Payment

ASC Quality Reporting

Biosimilars

Compounding

Contact Lens Safety

Drug Waste

Eyedrop Refills

Lasik Surgery

Medicare Fee Schedule

Medicare Access and CHIP Reauthorization Act

Merit-Based Incentive Payment System

Open Payments/Financial Disclosures

Performance Data Releases

Physician Quality Reporting System

Prior Authorization

Research Funding

Rubber Bullets

Scope of Practice

Step Therapy

Tech Innovation/FDA Process

Telemedicine

Truth in Advertising

VA National Standards of Practice

Veterans Eye Care

Vision Screenings

Eye on Advocacy
News and views on the regulatory, legislative and political issues impacting ophthalmology in Washington, D.C., and around the United States. Articles featured in the Academy's weekly Washington Report Express email newsletter.
1-10 of 43 results
1 2 3 4 5

Akorn Bankruptcy to Shrink Ophthalmic Drug Supply

FEB 24, 2023 in Drug Shortages, Patient Safety, Drug Pricing

Bankruptcy proceedings will likely affect the manufacture of phenylephrine, atropine and fluorescein.

Comments 0

Views 40

FDA Announces Erythromycin Ophthalmic Ointment Shortage

JUL 14, 2022 in Drug Shortages, FDA/Tech Innovation

The Academy has been engaged with the Food and Drug Administration and manufacturers about ensuring supply of this critical product.

Comments 0

Views 2

Academy Presses FDA for Policy Changes to Address Critical Drug Shortages

JUN 23, 2022 in Drug Shortages, Compounding, FDA/Tech Innovation, Patient Safety

With persistent drug shortages impacting patient care in ophthalmology, the Academy urged the Food and Drug Administration to change policy to enable 503B outsourcing facilities to fill drug access gaps.

Comments 0

Views 2

Academy Backs Senate Bill to Preserve Longstanding Approval Process for Ophthalmic Drugs

MAY 26, 2022 in Drug Pricing, Drug Shortages, Patient Safety

The Academy has helped draft a bill to ensure the continued safe and effective regulation of ophthalmic drugs by addressing a new potentially burdensome FDA rule on combination products. .

Comments 0

Views 1

Ask Your State Society to Endorse Multisociety Position Statement on Drug Waste

MAY 18, 2022 in Drug Shortages, Drug Waste

The Academy urges the ophthalmic community to limit drug waste and reduce the footprint of ophthalmology surgery.

Comments 0

Views 0

Mid-Year Forum 2022: Medical Waste

APR 26, 2022 in Drug Shortages, Drug Pricing, Drug Waste

Eliminating medical waste in health care facilities is critical to lowering health care costs, ensuring continued access to key drugs and promoting better environmental outcomes. This session served to provide an overview of the current challenges, highlight ophthalmology le…

Comments 0

Views 1

Academy Issues First Biosimilars Policy for Ophthalmic Practices

FEB 10, 2022 in Drug Shortages

A new Academy policy statement recommends biosimilars should have sufficient research demonstrating their safety and effectiveness for treatment of eye diseases before they are routinely recommended for ophthalmologic use.

Comments 0

Views 0

Academy Influences AMA House of Delegates’ Policies on Payment, Cyber Security

DEC 09, 2021 in Medicare Fee Schedule, Sequestration, Health IT, Drug Shortages

The American Medical Association’s House of Delegates enacted several policies that affect ophthalmology last month, including a medical drug waste policy and resolutions to address Medicare sequestration cuts, budget neutrality and ransomware.

Comments 0

Views 0

Ophthalmic Drug Waste Is Target of New Academy-Driven AMA Policy

NOV 24, 2021 in Drug Waste, Eyedrop Refills, Drug Shortages, Congressional Advocacy, Drug Pricing

The Academy’s resolute advocacy in the AMA places us in the vanguard of promoting medical waste reduction and green surgery across the House of Delegates.

Comments 0

Views 2

Zirabev, Mvasi May Not Be Used to Treat Eye Disease, CMS Says

NOV 09, 2021 in Patient Safety, Drug Shortages, Step Therapy, Medicare Advantage

CMS has told Medicare Advantage plans that the two biosimilars, which are not clinically proven to treat eye disease and are potentially dangerous to ophthalmology patients, may not be used as substitutes for Avastin or be required in their step therapy programs.

Comments 0

Views 4

1-10 of 43 results
1 2 3 4 5

Become an Advocate

GET INVOLVED
OPHTHPAC^®

JOIN
Surgical Scope Fund

INVEST
The Academy Store

Core Knowledge Retina

Core Knowledge Glaucoma

2023-2024 Basic and Clinical Science Course, Complete Print Set

2023-2024 Basic and Clinical Science Course, Complete eBook Set

2023-2024 Basic and Clinical Science Course, Complete Print and eBook Set

2023-2024 Basic and Clinical Science Course, Residency Print Set

2023-2024 Basic and Clinical Science Course, Residency eBook Set

Basic and Clinical Science Course Complete Set

Basic and Clinical Science Course Residency Set

Basic and Clinical Science Course, Section 01: Update on General Medicine

Basic and Clinical Science Course, Section 02: Fundamentals and Principles of Ophthalmology

Basic and Clinical Science Course, Section 03: Clinical Optics and Vision Rehabilitation

Basic and Clinical Science Course, Section 04: Ophthalmic Pathology and Intraocular Tumors

Basic and Clinical Science Course, Section 05: Neuro-Ophthalmology

Basic and Clinical Science Course, Section 06: Pediatric Ophthalmology and Strabismus

Basic and Clinical Science Course, Section 07: Oculofacial Plastic and Orbital Surgery

Basic and Clinical Science Course, Section 08: External Disease and Cornea

Basic and Clinical Science Course, Section 09: Uveitis and Ocular Inflammation

Basic and Clinical Science Course, Section 10: Glaucoma

Basic and Clinical Science Course, Section 11: Lens and Cataract

Basic and Clinical Science Course, Section 12: Retina and Vitreous

Basic and Clinical Science Course, Section 13: Refractive Surgery

All Eyes on DEI: Positives, Pitfalls and Priorities: Webinar

2023 Fundamentals of Ophthalmic Coding Course (Live Virtual)

2023 Fundamentals of Ophthalmic Coding Course (Recording)

Fundamentals of Ophthalmic Coding Course (Virtual)

2023 IRIS Registry (Intelligent Research in Sight) Preparation Kit

Academy Consultations - Hourly

Academy Consultations - Half Day

Academy Consultations - Full Day
Most Commented

Loading, please wait...

There are no comments available.

Most Viewed

Loading, please wait...

Most Viewed content is not available.
Dates & Deadlines

There are no scheduled meetings or deadlines.

Save event

Select your calendar system below.

Google Calendar

Outlook or Apple Calendar

Yahoo Calendar

Note: You will have to be signed in to your calendar and may have to enable pop-ups to add events.

Issue Summaries

Become an Advocate

OPHTHPAC^®

Surgical Scope Fund

OUR SITES

FOLLOW THE ACADEMY

Issue Summaries

Eye on Advocacy

Become an Advocate

OPHTHPAC®

Surgical Scope Fund

OUR SITES

FOLLOW THE ACADEMY

OPHTHPAC^®